PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Harman MS et al. – Regularly ovulating women of reproductive age are significantly protected against CVD compared with men, but CVD increases within 10 years of menopause to levels matching or exceeding incidence rates among men,13 suggesting that ovarian estrogen may help protect women against atherosclerosis. This observation led to the corollary hypothesis that treatment of postmenopausal women with estrogens (menopausal hormone therapy [MHT]) might prevent the postmenopausal increase in CVD rates. Yet, despite more than 30 years of research attempting to define whether and how postmenopausal estrogen replacement might protect women against CVD, the issue remains uncertain and, indeed, controversial.

   

Today in Clinical Pharmacology...keeping you current

U.S. Opioid Risk Management Initiatives
Pain: Clinical Updates (IASP’s clinical newsletter), 11/20/09

Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09

Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09

Today in Family Medicine...keeping you current

When should you consider implanted nerve stimulators for lower back pain?
APCToday, 11/20/09

Management of back pain in pregnancy
Techniques in Regional Anesthesia and Pain Management, 11/20/09

U.S. Opioid Risk Management Initiatives
Pain: Clinical Updates (IASP’s clinical newsletter), 11/20/09

Today in Obstetrics/Gynecology...keeping you current

Management of back pain in pregnancy
Techniques in Regional Anesthesia and Pain Management, 11/20/09

Urinary incontinence and waist circumference in older women
Age and Aging, 11/20/09

The EVAPIL scale, a new tool to assess tolerance of oral contraceptives
Contraception, 11/20/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address